Thanks to Prof. Henrich from Charité University Hospital Berlin for delivering a fantastic keynote lecture on advancements and innovations in postpartum haemorrhage (PPH) management at the Labour and Delivery Congress in Parma, Italy, this week.
Reflecting on his extensive experience and the positive impact that he and his team have made on the outcomes of thousands of mothers across Germany, Prof. Henrich presented valuable insights into managing obstetric haemorrhage. His discussion highlighted the significant role that CELOX PPH, developed by our partner Medtrade, has played in improving maternal care.
Key findings from the CELOX PPH Series review (covering 102 patients with uterine atony) include:
These outcomes underscore the life-saving potential of CELOX PPH in addressing the challenges of obstetric haemorrhage.
To learn more about this groundbreaking product and to connect with the team at CELOX PPH, distributors are encouraged to log in to their SehaMed account and reach out directly.